PE20001351A1 - Composiciones de aciclovir que contienen dimeticona - Google Patents

Composiciones de aciclovir que contienen dimeticona

Info

Publication number
PE20001351A1
PE20001351A1 PE1999001302A PE00130299A PE20001351A1 PE 20001351 A1 PE20001351 A1 PE 20001351A1 PE 1999001302 A PE1999001302 A PE 1999001302A PE 00130299 A PE00130299 A PE 00130299A PE 20001351 A1 PE20001351 A1 PE 20001351A1
Authority
PE
Peru
Prior art keywords
aciclovir
compositions
dimeticone
water
containing dimeticone
Prior art date
Application number
PE1999001302A
Other languages
English (en)
Inventor
Parbinder Singh Cheema
David Gower
Andrew David Mounter
Timothy Giles Sabey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20001351(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20001351A1 publication Critical patent/PE20001351A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

SE REFIERE A UNA FORMULACION FARMACEUTICA TOPICA DE ACEITE EN AGUA QUE COMPRENDE: ACICLOVIR 9-(2-HIDROXIETOXIMETIL)GUANINA, DIMETICONA UTILIZANDOSE DE 0,5% P/P A 1,5%P/P; AL MENOS 30% P/P DE UN ALCOHOL POLIHIDRICO TAL COMO PROPILENGLICOL MISCIBLE EN AGUA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES VIRALES TAL COMO HERPES
PE1999001302A 1998-12-23 1999-12-21 Composiciones de aciclovir que contienen dimeticona PE20001351A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments

Publications (1)

Publication Number Publication Date
PE20001351A1 true PE20001351A1 (es) 2000-12-14

Family

ID=10845017

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001302A PE20001351A1 (es) 1998-12-23 1999-12-21 Composiciones de aciclovir que contienen dimeticona

Country Status (27)

Country Link
EP (1) EP1140117B1 (es)
JP (1) JP4145493B2 (es)
KR (1) KR100707329B1 (es)
CN (2) CN1191834C (es)
AR (1) AR021993A1 (es)
AT (1) ATE236644T1 (es)
AU (1) AU768989B2 (es)
BR (1) BR9916524A (es)
CA (1) CA2356895A1 (es)
CZ (1) CZ295770B6 (es)
DE (2) DE29924428U1 (es)
DK (1) DK1140117T3 (es)
ES (1) ES2196910T3 (es)
GB (2) GB9828620D0 (es)
HK (2) HK1039275A1 (es)
HU (1) HU230542B1 (es)
IL (2) IL143833A0 (es)
NO (1) NO322090B1 (es)
NZ (1) NZ512457A (es)
PE (1) PE20001351A1 (es)
PL (1) PL196629B1 (es)
PT (1) PT1140117E (es)
SI (1) SI1140117T1 (es)
TR (1) TR200102482T2 (es)
TW (1) TW585768B (es)
WO (1) WO2000038695A2 (es)
ZA (1) ZA200105071B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
BRPI0914454A2 (pt) * 2008-10-21 2015-10-27 Novodermix Internat Ltd "composição para o tratamento do tecido epitelial"
US20130324502A1 (en) * 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0394928A1 (en) * 1989-04-24 1990-10-31 Syntex (U.S.A.) Inc. Topical antiviral pharmaceutical composition containing a nonionic surfactant
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
CN100415237C (zh) 2008-09-03
HU230542B1 (hu) 2016-11-28
EP1140117B1 (en) 2003-04-09
ES2196910T3 (es) 2003-12-16
JP2002542149A (ja) 2002-12-10
CZ295770B6 (cs) 2005-11-16
CA2356895A1 (en) 2000-07-06
PT1140117E (pt) 2003-08-29
DE29924428U1 (de) 2003-08-28
NO20013103D0 (no) 2001-06-21
GB2362105A (en) 2001-11-14
HUP0104594A2 (en) 2002-06-29
JP4145493B2 (ja) 2008-09-03
CN1539421A (zh) 2004-10-27
IL143833A (en) 2006-12-31
NO322090B1 (no) 2006-08-14
WO2000038695A3 (en) 2000-10-26
DE69906796T2 (de) 2004-01-29
SI1140117T1 (en) 2003-12-31
NZ512457A (en) 2003-10-31
KR20010099932A (ko) 2001-11-09
AU768989B2 (en) 2004-01-15
HK1067548A1 (en) 2005-04-15
AR021993A1 (es) 2002-09-04
DE69906796D1 (de) 2003-05-15
GB9828620D0 (en) 1999-02-17
ZA200105071B (en) 2002-09-20
GB0117795D0 (en) 2001-09-12
ATE236644T1 (de) 2003-04-15
NO20013103L (no) 2001-08-20
PL349505A1 (en) 2002-07-29
HK1039275A1 (zh) 2002-04-19
IL143833A0 (en) 2002-04-21
AU2099700A (en) 2000-07-31
EP1140117A2 (en) 2001-10-10
WO2000038695A2 (en) 2000-07-06
HUP0104594A3 (en) 2002-12-28
CN1191834C (zh) 2005-03-09
CN1334737A (zh) 2002-02-06
GB2362105B (en) 2003-06-18
PL196629B1 (pl) 2008-01-31
DK1140117T3 (da) 2003-07-21
BR9916524A (pt) 2001-10-02
KR100707329B1 (ko) 2007-04-13
TW585768B (en) 2004-05-01
CZ20012332A3 (cs) 2001-12-12
TR200102482T2 (tr) 2003-03-21

Similar Documents

Publication Publication Date Title
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
PE20040549A1 (es) Composiciones para remover manchas de superficies dentales y metodos de fabricacion y uso de ellas
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
AR110010A2 (es) Composición farmacéutica formulada en una forma de dosis única de 2-[6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
GT200000005A (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer.
ATE331517T1 (de) Pharmazeutische zusammenstellungen
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
SG156624A1 (en) Organo-gel formulations for therapeutic applications
ES2193391T3 (es) Antagonistas muscarinicos.
AR021539A1 (es) Preparaciones topicas anhidras para la piel
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
BRPI0014869B8 (pt) prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
ES2174591T3 (es) Composiciones cosmeticas para las axilas con acetato de alquilo inferior.
ES8305363A1 (es) Un procedimiento para preparar una composicion farmaceutica que contiene 9-(2-hidroxietoximetil)guanina.
AR003893A1 (es) Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
KR910000111A (ko) 치아 구조의 광물질 소실된 부분을 광물질 분재보급 시키기 위한 방법
AR029347A1 (es) Compuesto de adenina, compuesto de isognanina y 2,6-ditioxantina como precursor del mismo, uso de dichos compuestos para preparar una composicion farmaceutica y dicha composicion farmaceutica
BR0315663A (pt) Formulações de depósito de agentes ativos de aril-heterocìclicos na forma de uma suspensão
AR064262A1 (es) Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato
CL2004001325A1 (es) Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed